Oncology Institute (DFPH) Share-based Compensation (2021 - 2026)

Oncology Institute (DFPH) has 6 years of Share-based Compensation data on file, last reported at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 15.64% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (down 43.93% YoY), and the FY2025 full-year result was $4.6 million, down 59.19% from the prior year.
• Share-based Compensation for Q1 2026 stood at $1.7 million, up from $1.3 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $8.6 million in Q1 2022 and bottomed at $752000.0 in Q2 2025.
• The 5-year median for Share-based Compensation is $4.1 million (2023), against an average of $3.7 million.
• The widest annual swing landed in 2022, when Share-based Compensation jumped 20264.29%; it then sank 77.8% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $6.1 million in 2022, then slumped by 32.8% to $4.1 million in 2023, then plunged by 68.4% to $1.3 million in 2024, then rose by 2.17% to $1.3 million in 2025, then grew by 28.02% to $1.7 million in 2026.
• The last three Share-based Compensation figures came in at $1.7 million (Q1 2026), $1.3 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.

Peer Comparison